Astrazeneca Plc (AZN) Institutional Ownership

Ownership Summary

Astrazeneca Plc (NYSE:AZN) is held by 1,330 institutional investors per 13F filings through December 2025.

• Their combined ownership stood at 14.2% of outstanding shares in December 2025, down from 17.4% in September 2025.
• Their total shares held in AZN decreased -6.71% from the prior quarter, while the number of investors in Astrazeneca increased 10.47% year over year.
• Of these 1,330 funds, 730 grew their exposure to Astrazeneca, 392 cut back, and 208 maintained positions.
• The aggregate institutional position in Astrazeneca amounted to 221.45Mn shares as of December 2025, down by 15.94Mn shares quarter on quarter, and down 49.66Mn shares year over year.
• INVESTOR AB is the top holder of Astrazeneca as of December 31, 2025, with 51.59Mn shares representing 3.3% of outstanding stock.
• The most significant purchases of AZN for the quarter ending December 2025 came from INVESTOR AB (51.59Mn), VANGUARD CAPITAL MANAGEMENT LLC (45.04Mn), Capital International Investors (34.39Mn), FMR LLC (29.6Mn), Capital World Investors (28.26Mn).
• The biggest sellers of Astrazeneca for the quarter ending December 2025 included L & S Advisors Inc (18.73K), Icon Wealth Advisors, LLC (1.8K), EverSource Wealth Advisors, LLC (1.57K), Valeo Financial Advisors, LLC (1.17K), Boston Common Asset Management, LLC (752).
• Per Business Quant, the top 10 investors in AZN for the quarter ending December 2025 include INVESTOR AB (51.59Mn), VANGUARD CAPITAL MANAGEMENT LLC (45.04Mn), Capital International Investors (34.39Mn), FMR LLC (29.6Mn), Capital World Investors (28.26Mn), Legal & General Group Plc (25.85Mn), Janus Henderson Group Plc (23.9Mn), WELLINGTON MANAGEMENT GROUP LLP (23.75Mn), PRICE T ROWE ASSOCIATES INC /MD/ (19.49Mn), Bank Of America Corp /De/ (19.06Mn).